Skip to content
Colorectal Cancer Clinical Trials

San Francisco, California

Colorectal cancer clinical trials in San Francisco, CA

29 colorectal cancer studies are recruiting participants at sites in San Francisco as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.

Call (888) 385-9581
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

San Francisco at a glance

  • 29 studies are recruiting at a site in San Francisco.
  • By phase: Phase 1 (8), Phase 1/2 (8), Phase 2 (1), Phase 2/3 (2), Phase 3 (3), No phase (3), Observational (4). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (21), university, hospital or other (8).
  • Most recent update to one of these records: November 5, 2026.

Studies recruiting in San Francisco

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Summit Therapeutics
    Registry record
    NCT07228832 · updated
  2. A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    EMD Serono Research & Development Institute, Inc.
    Study site
    UCSF Mount Zion Medical Ctr
    Registry record
    NCT07549412 · updated
  3. Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    NRG Oncology
    Study sites
    California Pacific Medical Center-Pacific Campus · Kaiser Permanente-San Francisco
    Registry record
    NCT05174169 · updated
  4. Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Wake Forest University Health Sciences
    Study site
    Kaiser Permanente-San Francisco
    Registry record
    NCT06418204 · updated
  5. Distance-Based Exercise to Preserve Function and Prevent Disability

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Kaiser Permanente-San Francisco
    Registry record
    NCT07059884 · updated
  6. Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    UCSF Helen Diller Family Comprehensive Cancer Center
    Registry record
    NCT07397338 · updated
  7. A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Relay Therapeutics, Inc.
    Study site
    University of California, San Francisco
    Registry record
    NCT07584226 · updated
  8. LYL273 for Patients With Relapsed or Refractory mCRC

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Lyell Immunopharma, Inc.
    Study site
    University of California San Francisco Medical Center
    Registry record
    NCT05319314 · updated
  9. A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    California Pacific Medical Center - Pacific Campus
    Registry record
    NCT07221357 · updated
  10. Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Institut de Recherches Internationales Servier
    Study site
    University of California, San Francisco (UCSF)
    Registry record
    NCT05786924 · updated
  11. Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study sites
    UCSF Medical Center · UCSF at China Basin · UCSF at Mount Zion
    Registry record
    NCT07222800 · updated
  12. FOG-001 in Locally Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Parabilis Medicines, Inc.
    Study site
    University of California San Francisco, Helen Diller Family Comprehensive Cancer Center
    Registry record
    NCT05919264 · updated
  13. A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    EvolveImmune United, Inc
    Study site
    UCSF Medical center Parnassus
    Registry record
    NCT07217171 · updated
  14. Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

    • Phase 1
    • Ages 12 to 85
    • All sexes
    Sponsor
    Inhibrx Biosciences, Inc
    Study site
    University of California, San Francisco (UCSF)
    Registry record
    NCT03715933 · updated
  15. A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Cartography Biosciences
    Registry record
    NCT07321106 · updated
  16. Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

    • Phase 1/2
    • From 12 months, up to 30 years
    • All sexes
    Sponsor
    Children's Oncology Group
    Study site
    UCSF Medical Center-Mission Bay
    Registry record
    NCT04851119 · updated
  17. Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    University of California, San Francisco
    Study site
    University of California, San Francisco
    Registry record
    NCT04221893 · updated
  18. A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    ArriVent BioPharma, Inc.
    Registry record
    NCT07066657 · updated
  19. A Study of DM002 in Patients With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
    Study site
    University of California San Francisco Cancer Center
    Registry record
    NCT06751329 · updated
  20. BBO-11818 in Adult Subjects With KRAS Mutant Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
    Study site
    University of California San Francisco Helen Diller Family Comprehensive Cancer Center
    Registry record
    NCT06917079 · updated
  21. Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    AIDS Malignancy Consortium
    Study site
    University of California, San Francisco
    Registry record
    NCT05663502 · updated
  22. Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Stanford University
    Study sites
    Kaiser Foundation Research Institute · University of San Francisco · Zuckerberg San Francisco General
    Registry record
    NCT05297734 · updated
  23. A Study of MGC028 in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    MacroGenics
    Study site
    UCSF - Helen Diller Family Cancer Center
    Registry record
    NCT06723236 · updated
  24. Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    MBrace Therapeutics
    Study site
    UCSF Helen Diller Family Comprehensive Cancer Center
    Registry record
    NCT07145255 · updated
  25. A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Clasp Therapeutics, Inc.
    Study site
    University of California San Francisco
    Registry record
    NCT06778863 · updated
  26. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    • Observational
    • All ages
    • All sexes
    Sponsor
    Massive Bio, Inc.
    Study site
    Massive Bio SYNERGY-AI site
    Registry record
    NCT03452774 · updated
  27. A Study of NX-1607 in Adults With Advanced Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Nurix Therapeutics, Inc.
    Study site
    University of California, San Francisco
    Registry record
    NCT05107674 · updated
  28. A Multicenter Cancer Biospecimen Collection Study

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Cofactor Genomics, Inc.
    Study site
    Curebase
    Registry record
    NCT04510129 · updated
  29. A Study of IBI363 in Subjects with Advanced Solid Malignancies

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Innovent Biologics (Suzhou) Co. Ltd.
    Study site
    University of California, San Francisco (UCSF)
    Registry record
    NCT06281678 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in San Francisco, CA on ClinicalTrials.gov.

Ask about studies near San Francisco

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in California

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 385-9581

or send a short form

How should we reach you?

Call